Blank medicinskogo zaklyucheniya po prikazu 302 n main. Featured products of torrent: cabosoft inj, calflash, capehope, cardiwell, cardiwell plus, centron, 1-up, chepatron, chymoral-br, cipride, clobator, coloni. Torrent Pharma has crossed many geographical boundaries with presence in more than 40 countries. The Company is ranked first amongst Indian Companies for having largest market share in Brazil and Germany. Therapeutic Areas Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India.

Torrent Pharma, the flagship company of Torrent Group, is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. It has also forayed into the therapeutic segments of nephrology and oncology while also strengthening its focus on gynecology and pediatric segments. Right from pioneering niche marketing in India to earning the sobriquet of ‘the Company with the most first launches’, Torrent Pharma has always remained ahead of its competition. Torrent Pharma’s competitive advantage stems from its world-class manufacturing facilities, advanced R&D capabilities, extensive domestic network and a widespread global presence. It has three world-class manufacturing facilities at Indrad (Gujarat), Baddi (Himachal Pradesh) and Sikkim. The facilities are approved by USFDA, WHO, MHRA, TGA and other global regulatory bodies.

A new facility is taking shape at Dahej SEZ in Western India, which will cater to the international markets. Torrent Pharma is the sole manufacturer of Insulin Formulations for Novo Nordisk in India since the early ‘90s and has also set up a dedicated formulation and packaging facility for Insulin. Source: Torrent Pharmaceuticals Ltd: Leader in the pharmaceutical industry 2015 Torrent Pharma recognized as the Most Promising Company of the Year at the 10th CNBC TV18 India Business Leader Awards 2014. 2014 Acquired Elder Pharma’s Indentified Indian Branded Formulation Business in India and Nepal. 2011 Forayed into oncology segment. 2006 The API and formulations manufacturing facilities located at Indrad (Gujarat, India) got USFDA approval. 2000 Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award for its Formulations facility.

Updated: January, 2015. • • • • • • • • • • • • • • • • • • • • • • Copyright © 2010-2019 India Brand Equity Foundation All material, information, data, images or content on this website is subject to copyright or other applicable intellectual property laws and no part of it can be reproduced in any form (including paper or electronic form) without prior written consent and approval from IBEF. Infringements are subject to prosecution under the applicable laws. For consent related queries and conditions, please write to An initiative of the.

Ahmedabad-headquartered drug major Torrent Pharma has managed to turn around its business in Brazil, where it is the largest Indian generics player, with revenue growing by 25 per cent in April-December to Rs 484 crore. During the third quarter, the company's Brazil business posted revenue growth of 35 per cent, year on year, to Rs 159 crore. In 2015-16, Torrent’s revenue in Brazil declined 17 per cent to Rs 506 crore. A company spokesperson said the devaluation of the Brazilian real had overshadowed market growth. In 2015-16, revenue declined 17 per cent in dollar terms but grew. • Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact information will be shared with the partners associated with this program, who contribute towards subsidizing the offer.

By subscribing to this product you acknowledge and accept that our Partners may choose to contact you with offers of their products and services. • This is an optional offer - Not comfortable with sharing personal data - please opt for the full price offer which requires you to share minimal information NOTE. • This product is a monthly auto renewal product.